Structure-Based Screen Identification of a Mammalian Ste20-Like Kinase 4 (MST4) Inhibitor With Therapeutic Potential for Pituitary Tumors

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-15-0703
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Correction: Mammalian Ste20-Like Kinase and SAV1 Promote 3t3-L1 Adipocyte Differentiation by Activation of PPARγ

PLoS ONE
Multidisciplinary
2015English

Kinase Inhibitor Screening Identifies CDK4 as a Potential Therapeutic Target for Melanoma

International Journal of Oncology
Cancer ResearchOncology
2015English

Phosphoinositide-3 Kinase/Protein Kinase-B/Mammalian Target of Rapamycin Pathway in Psoriasis Pathogenesis. A Potential Therapeutic Target?

Acta Dermato-Venereologica
DermatologyMedicine
2014English

Targeting theNotch Pathway: A Potential Therapeutic Approach for Desmoid Tumors

Cancer
Cancer ResearchOncology
2015English

NPM1 as a Potential Therapeutic Target for Atypical Teratoid/Rhabd Tumors

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Therapeutic Effect of Palbociclib in Chondrosarcoma: Implication of Cyclin-Dependent Kinase 4 as a Potential Target

Cell Communication and Signaling
BiochemistryCell BiologyMolecular Biology
2019English

Macrophages Associated With Tumors as Potential Targets and Therapeutic Intermediates

Nanomedicine
DevelopmentMaterials ScienceNanoscienceMedicineBioengineeringNanotechnologyBiomedical Engineering
2014English

Structure-Based Identification of a Ricin Inhibitor 1 1Edited by R. Huber

Journal of Molecular Biology
Structural BiologyMolecular BiologyBiophysics
1997English

Identification of Regulatory Phosphorylation Sites in a Cell Volume– And Ste20 Kinase–dependent ClC Anion Channel

Journal of General Physiology
Physiology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy